Sponsors: Translating Research & Technology into Life Science Products a French-Italian Platform Comitato Nazionale per la Biosicurezza e le Biotecnologie Ministero dell Istruzione, dell Università e della Ricerca Università Italo- Francese Organisers: Fondazione Istituto Banco di Napoli
High Patronage: Ministero dell Istruzione, dell Università e della Ricerca. Sponsors: Supporters: Comitato Nazionale per la Biosicurezza e le Biotecnologie; Università Italo-Francese, Torino; Università Telematica Guglielmo Marconi, Roma; Fondazione Istituto Banco di Napoli, Napoli; CEINGE Biotecnologie Avanzate, Napoli Chiesi Farmaceutici SpA, Parma. Italian Bioindustry Association, Milano; France Biotech, Paris; Swiss Biotech Association, Zurich. Organisers: Italian Embassy in Paris, Scientific Office; Biovision; GMG Life Sciences; inno; SGC Sviluppo Gestione Controllo. Pag. 2
Index Content Goals Issues Programme Speakers Advisory Board Information in this document is subject to changes. Pag. 3
Content This one day meeting will focus on research, clinical development and manufacturing in life science. The main goal of the event is to assess available incentives, competitive advantages, opportunities and challenges in France and Italy. The discussion will centre around solutions and partnerships to foster integration and leverage existing bilateral cooperation. Participants to the sessions include national and regional senior policy and decision makers in health care, industry experts, entrepreneurs and researchers in life science. Specific commitments and follow-through are expected from all participants to jointly bridge gaps. The advisory board offers strategic guidance and support for future activities. Pag. 4
Goals Establish a permanent platform in the biotech and life science space to produce recommendations, identify and explore French - Italian partnerships and collaborations between government organisations, public and private research institutions, associations and industrial companies. Pag. 5
Issues Institutional Perspective: opportunities, incentives and solutions for investments in life science. Industrial Insights: successful partnerships and collaborations between France and Italy. Scientific Perspective: presentation of specific initiatives focusing on Cancer Research; Clinical Development; Biological Resource Centres. Pag. 6
Programme Details Date : May 26 th, 2005 By invitation only Venue : Hotel Royal Monceau Tel.: +33 1 4299 8800 37, Avenue Hoche Contact : 75008 Paris Mrs.Virginia Ferrante Tel. +39 02 7209 4568 Fax. +39 02 8909 7119 Mail: v.ferrante@sgcnet.it Web site : www.frenchbiotech.com/fibp www.jointly4biotech.com Pag. 7
Programme Schedule 10:00 10:45 10:45 11:00 Welcome Coffee and Registration Welcome Address: Francesco Grasso Gamil G. de Chadarevian Jean-Alexis Grimaud 11:00 13:15 Session I Institutional Perspective Moderator: Mauro Magnani Speakers: Pierre-Noel Lirsac Lionel Segard Thierry Philip Eric Poincelet Luigi Rossi Bernardi Leonardo Santi Patrik Frei Gwennael Joliff-Botrel Leonardo Vingiani Pag. 8
Programme Schedule 13:15 14:30 Lunch 14:30 15:30 Session II Industrial Insight Moderator: Gamil G. de Chadarevian Speakers: Patrik Tricoli Paolo Chiesi Massimo Radaelli Henri Chibret Michele Garufi Hervé Brailly Bénédicte Fournes Pag. 9
Programme Schedule 15:30 16:20 Session III - Scientific Perspective Moderator: Jean-Alexis Grimaud, Thierry Philip Learning from the US Experience in Nanotechnology and Oncology Research : Carlo Croce Mauro Ferrari Generate Additional Partnership Opportunities in Cancer Research : François Sigaux Pierfranco Conte Generate Additional Partnerships in Clinical Development : Pierrette Zorzi Guido Rasi Giorgio Parmiani 16:30 16:45 Coffee Break Pag. 10
Programme Schedule 16:45 17:20 Session III- Scientific Perspective Moderator: Jean-Alexis Grimaud Generate Additional Partnerships in Biological Resource Centres (Repositories) : Jean Deregnaucourt Francesco Salvatore Giampiero Bricca Domenico Coviello 17:20 17:30 Policy, Industrial and Scientific Issues: First Evaluation of the Questionnaire Jean Marsac Pag. 11
Programme Schedule 17:30 18:15 Interactive Work Session Enhancement of a French-Italian Platform: Milestones and Road Map Moderators: Jean Marsac, Leonardo Santi Panelists: Gamil G. de Chadarevian Angelita de Francisco Pier Maria Furlan Guido Hillebrands Luigi Rossi Bernardi Tommaso Russo Ian Metcalfe 18:15 18:30 Summary and Future Actions Alessandro Campana Jean Marsac Pag. 12
Italian Speakers (1/2) Alessandro Campana, CEO, SGC Sviluppo Gestione Controllo; Paolo Chiesi, Vice President and R&D Director, Chiesi Farmaceutici, Parma; Pierfranco Conte, Professor, Istituto Superiore Oncologia, Modena; Domenico Coviello, Expert, National Biological Resource Centre (CNRB), Genova; Carlo Croce, Professor of Department of Molecular Virology, Immunology and Medical Genetics, Ohio State University; Gamil G. de Chadarevian, Biovision Advisor, Biotech Entrepreneur; Mauro Ferrari, Professor of Biomedical Engineering and Internal Medicine, Ohio State University Medical Center; Pier Maria Furlan, Secretary General, Università Italo-Francese, Torino; Francesco Grasso, Professor, Scientific Counsellor, Italian Embassy in Paris; Mauro Magnani, Professor, Istituto di Chimica Biologica "G. Fornaini Università degli Studi "Carlo Bo, Urbino; Pag. 13
Italian Speakers (2/2) Giorgio Parmiani, Head of Human Tumor Immunotherapy Dept., Istituto Nazionale Tumori, Milano; Massimo Radaelli, President and CEO, Dompè International, Lausanne; Guido Rasi, CNR, Roma; Luigi Rossi Bernardi, Department Head., Ministry of Education, University and Research; Tommaso Russo, Director, Centre of Excellence GEAR, Napoli; Francesco Salvatore, President, CEINGE, Napoli; Leonardo Santi, Chairman, Comitato Nazionale per la Biosicurezza e le Biotecnologie, Roma; Stefano Vella, Director of Pharmaceutical Dept., Istituto Superiore Sanità, Roma; Leonardo Vingiani, General Manager, Assobiotec, Milano. Pag. 14
French Speakers (1/2) Giampiero Bricca, INSERM Faculté de Médecine Laennec; Hervé Brailly, CEO, Innate Pharma, Marseille; Henri Chibret, Chairman and CEO, Laboratoires Théa, Clermont-Ferrand; Angelita de Francisco, Secretary General, France Biotech, Paris; Jean Deregnaucourt, Director of Life Science Dept, Ministère de la Recherche et de la Technologie; Bénédicte Fournes, Scientific Director, ObeTherapy, Evry; Michele Garufi, Chairman and CEO, NicOx Research Institute Srl, Milano; Jean-Alexis Grimaud, Professor, Faculty of Medicine, University of Paris; Pierre-Noel Lirsac, Head of Biotech Division, Ministère de l Economie, des Finances et de l Industrie; Pag. 15
French Speakers (2/2) Jean Marsac, Professor of Medicine Faculty of Paris and Life Sciences Consultant; Jean Yves Neveux, Managing Director, Hopital Européen de Paris La Roseraie; Thierry Philip, Director of Cancer Institute Léon Berard, Lyon; Eric Poincelet, Managing Director, Fondation Scientifique Biovision, Lyon; Lionel Segard, Managing Director, INSERM TRANSFERT, Paris; François Sigaux, Director Institute of Haematology, Paris VII-Hôpital Saint-Louis; Patrik Tricoli, Director of Valorisation and Innovation, Sanofi-Aventis; Pierrette Zorzi, Director of bilogical product evaluation, Afssaps, Saint Denis. Other Speakers Patrik Frei (CH), CEO, Venture Valuation, Initiator Biotech Database Biotechgate, Zurich Ian Metcalfe (CH), Swiss Biotech Association and Berna Biotech. Bern. Pag. 16
Advisory Board Alessandro Campana, CEO, SGC Sviluppo Gestione Controllo; Gamil G. de Chadarevian, Biovision - Biotech Entrepreneur and Consultant; Samir de Chadarevian, Biovision - Biotech Entrepreneur and Consultant; Sergio Dompé, President, Dompé Farmaceutici; Mauro Ferrari, Professor of Biomedical Engineering and Internal Medicine, Ohio State University Medical Center; Martine Garreau, General Manager, GMG Life Sciences; Francesco Grasso, Scientific Counsellor, Italian Embassy in Paris; Jean-Alexis Grimaud, Faculty of Medicine, University of Paris; Jean Marsac, Faculty of Medicine, University of Paris. Pag. 17
We would like to extend a special thanks to the Italian Ministry for Education, University and Research and to the Italian Embassy in Paris for their continuous and strong support to this initiative.
Jointly for Biotech The International Platform www.jointly4biotech.com